SHEENA AMES: Open Payments
NPI 1972893899 · SALISBURY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,310 in 67 payments from 13 companies in 2025. Trend: 2023 $1,681 · 2024 $1,398 · 2025 $1,310
Food & beverage: $1,310
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 9 | $274 |
| PFIZER INC. | 16 | $248 |
| ABBVIE INC. | 13 | $187 |
| Astellas Pharma US Inc | 4 | $107 |
| Phathom Pharmaceuticals, Inc. | 6 | $98 |
| Lilly USA, LLC | 5 | $93 |
| Novo Nordisk Inc | 4 | $74 |
| Xeris Pharmaceuticals, Inc. | 2 | $47 |
| Exact Sciences Corporation | 2 | $47 |
| AstraZeneca Pharmaceuticals LP | 2 | $46 |
Products named: EVENITY, Veozah, NURTEC ODT, QULIPTA, VOQUEZNA, UBRELVY, MOUNJARO, PREVNAR 20.
Industry payments across MD — which companies pay providers there.
